0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Eye Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-119
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dry Eye Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Dry Eye Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-119
Report
July 2025
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Eye Drugs Market Size

In 2024, the global market size of Dry Eye Drugs was estimated to be worth US$ 10740 million and is forecast to reach approximately US$ 23500 million by 2031 with a CAGR of 12.0% during the forecast period 2025-2031.

Dry Eye Drugs Market

Dry Eye Drugs Market

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dry Eye Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Drugs.
The Dry Eye Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dry Eye Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Dry Eye Drugs Market Report

Report Metric Details
Report Name Dry Eye Drugs Market
CAGR 12.0%
Segment by Type
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Other
Segment by Application
  • Hospital
  • Drug Stores
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan, Novartis AG, Bausch Health, Santen Pharma, Takeda, Johnson & Johnson, United Laboratories, Senju Pharmaceutical, Jianfeng Group, Eusan GMBH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Dry Eye Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Dry Eye Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Eye Drugs sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Dry Eye Drugs Market?

Ans: Global top five manufacturers hold a share about 75%.

What is the Dry Eye Drugs Market share by type?

Ans: In terms of product, Artificial Tears is the largest segment, with a share over 85%.

Who are the main players in the Dry Eye Drugs Market report?

Ans: The main players in the Dry Eye Drugs Market are Allergan, Novartis AG, Bausch Health, Santen Pharma, Takeda, Johnson & Johnson, United Laboratories, Senju Pharmaceutical, Jianfeng Group, Eusan GMBH

What are the Application segmentation covered in the Dry Eye Drugs Market report?

Ans: The Applications covered in the Dry Eye Drugs Market report are Hospital, Drug Stores, Online Pharmacies

What are the Type segmentation covered in the Dry Eye Drugs Market report?

Ans: The Types covered in the Dry Eye Drugs Market report are Artificial Tears, Anti-inflammatory Drugs, Other

1 Study Coverage
1.1 Dry Eye Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Dry Eye Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dry Eye Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dry Eye Drugs Market Size Estimates and Forecasts
2.1.1 Global Dry Eye Drugs Revenue 2020-2031
2.1.2 Global Dry Eye Drugs Sales 2020-2031
2.2 Dry Eye Drugs Market Size by Region: 2024 Versus 2031
2.3 Dry Eye Drugs Sales by Region (2020-2031)
2.3.1 Global Dry Eye Drugs Sales by Region: 2020-2025
2.3.2 Global Dry Eye Drugs Sales Forecast by Region (2026-2031)
2.3.3 Global Dry Eye Drugs Sales Market Share by Region (2020-2031)
2.4 Dry Eye Drugs Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Dry Eye Drugs Revenue by Region: 2020-2025
2.4.2 Global Dry Eye Drugs Revenue Forecast by Region (2026-2031)
2.4.3 Global Dry Eye Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Dry Eye Drugs Sales by Type (2020-2031)
3.1.1.1 Global Dry Eye Drugs Sales Volume by Type (2020-2031)
3.1.1.2 Global Dry Eye Drugs Sales Market Share by Type (2020-2031)
3.1.2 Global Dry Eye Drugs Revenue by Type (2020-2031)
3.1.2.1 Global Dry Eye Drugs Revenue by Type (2020-2031)
3.1.2.2 Global Dry Eye Drugs Revenue Market Share by Type (2020-2031)
3.1.3 Dry Eye Drugs Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Dry Eye Drugs Sales by Application (2020-2031)
3.2.1.1 Global Dry Eye Drugs Sales Volume by Application (2020-2031)
3.2.1.2 Global Dry Eye Drugs Sales Market Share by Application (2020-2031)
3.2.2 Global Dry Eye Drugs Revenue by Application (2020-2031)
3.2.2.1 Global Dry Eye Drugs Revenue by Application (2020-2031)
3.2.2.2 Global Dry Eye Drugs Revenue Market Share by Application (2020-2031)
3.2.3 Dry Eye Drugs Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Artificial Tears of Dry Eye Drugs Revenue Market Share by Application
3.3.2 Anti-inflammatory Drugs of Dry Eye Drugs Revenue Market Share by Application
3.3.3 Other of Dry Eye Drugs Revenue Market Share by Application
4 Global Dry Eye Drugs by Manufacturers
4.1 Global Top Dry Eye Drugs Manufacturers by Sales (2020-2025)
4.1.1 Global Dry Eye Drugs Sales by Manufacturer (2020-2025)
4.1.2 Global Dry Eye Drugs Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Dry Eye Drugs Manufacturers by Revenue (2020-2025)
4.2.1 Global Dry Eye Drugs Revenue by Manufacturer (2020-2025)
4.2.2 Global Dry Eye Drugs Revenue Share by Manufacturer (2020-2025)
4.3 Global Dry Eye Drugs Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Dry Eye Drugs Manufacturers Covered: Ranking by Revenue
4.4.2 Global Dry Eye Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Dry Eye Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Dry Eye Drugs Manufacturing Base Distribution, Product Type
4.5.1 Dry Eye Drugs Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Dry Eye Drugs Market
4.5.3 Manufacturers Dry Eye Drugs Product Type and Application
4.5.4 Artificial Tears Market Sales of Dry Eye Drugs by Manufacturer
4.5.5 Anti-inflammatory Drugs Market Sales of Dry Eye Drugs by Manufacturer
4.5.6 Other Market Sales of Dry Eye Drugs by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Allergan
5.1.1 Allergan Company Information
5.1.2 Allergan Description, Business Overview
5.1.3 Allergan Dry Eye Drugs Products Offered
5.1.4 Allergan Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Allergan Dry Eye Drugs Sales by Product in 2024
5.1.6 Allergan Dry Eye Drugs Sales by Application in 2024
5.1.7 Allergan Dry Eye Drugs Sales by Geographic Area in 2024
5.1.8 Allergan Recent Developments
5.2 Novartis AG
5.2.1 Novartis AG Company Information
5.2.2 Novartis AG Description, Business Overview
5.2.3 Novartis AG Dry Eye Drugs Products Offered
5.2.4 Novartis AG Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Novartis AG Dry Eye Drugs Sales by Product in 2024
5.2.6 Novartis AG Dry Eye Drugs Sales by Application in 2024
5.2.7 Novartis AG Dry Eye Drugs Sales by Geographic Area in 2024
5.2.8 Novartis AG Recent Developments
5.3 Bausch Health
5.3.1 Bausch Health Company Information
5.3.2 Bausch Health Description, Business Overview
5.3.3 Bausch Health Dry Eye Drugs Products Offered
5.3.4 Bausch Health Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Bausch Health Dry Eye Drugs Sales by Product in 2024
5.3.6 Bausch Health Dry Eye Drugs Sales by Application in 2024
5.3.7 Bausch Health Dry Eye Drugs Sales by Geographic Area in 2024
5.3.8 Bausch Health Recent Developments
5.4 Santen Pharma
5.4.1 Santen Pharma Company Information
5.4.2 Santen Pharma Description, Business Overview
5.4.3 Santen Pharma Dry Eye Drugs Products Offered
5.4.4 Santen Pharma Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Santen Pharma Dry Eye Drugs Sales by Product in 2024
5.4.6 Santen Pharma Dry Eye Drugs Sales by Application in 2024
5.4.7 Santen Pharma Dry Eye Drugs Sales by Geographic Area in 2024
5.4.8 Santen Pharma Recent Developments
5.5 Takeda
5.5.1 Takeda Company Information
5.5.2 Takeda Description, Business Overview
5.5.3 Takeda Dry Eye Drugs Products Offered
5.5.4 Takeda Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Takeda Dry Eye Drugs Sales by Product in 2024
5.5.6 Takeda Dry Eye Drugs Sales by Application in 2024
5.5.7 Takeda Dry Eye Drugs Sales by Geographic Area in 2024
5.5.8 Takeda Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Company Information
5.6.2 Johnson & Johnson Description, Business Overview
5.6.3 Johnson & Johnson Dry Eye Drugs Products Offered
5.6.4 Johnson & Johnson Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Johnson & Johnson Dry Eye Drugs Sales by Product in 2024
5.6.6 Johnson & Johnson Dry Eye Drugs Sales by Application in 2024
5.6.7 Johnson & Johnson Dry Eye Drugs Sales by Geographic Area in 2024
5.6.8 Johnson & Johnson Recent Developments
5.7 United Laboratories
5.7.1 United Laboratories Company Information
5.7.2 United Laboratories Description, Business Overview
5.7.3 United Laboratories Dry Eye Drugs Products Offered
5.7.4 United Laboratories Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.7.5 United Laboratories Dry Eye Drugs Sales by Product in 2024
5.7.6 United Laboratories Dry Eye Drugs Sales by Application in 2024
5.7.7 United Laboratories Dry Eye Drugs Sales by Geographic Area in 2024
5.7.8 United Laboratories Recent Developments
5.8 Senju Pharmaceutical
5.8.1 Senju Pharmaceutical Company Information
5.8.2 Senju Pharmaceutical Description, Business Overview
5.8.3 Senju Pharmaceutical Dry Eye Drugs Products Offered
5.8.4 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Senju Pharmaceutical Dry Eye Drugs Sales by Product in 2024
5.8.6 Senju Pharmaceutical Dry Eye Drugs Sales by Application in 2024
5.8.7 Senju Pharmaceutical Dry Eye Drugs Sales by Geographic Area in 2024
5.8.8 Senju Pharmaceutical Recent Developments
5.9 Jianfeng Group
5.9.1 Jianfeng Group Company Information
5.9.2 Jianfeng Group Description, Business Overview
5.9.3 Jianfeng Group Dry Eye Drugs Products Offered
5.9.4 Jianfeng Group Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Jianfeng Group Dry Eye Drugs Sales by Product in 2024
5.9.6 Jianfeng Group Dry Eye Drugs Sales by Application in 2024
5.9.7 Jianfeng Group Dry Eye Drugs Sales by Geographic Area in 2024
5.9.8 Jianfeng Group Recent Developments
5.10 Eusan GMBH
5.10.1 Eusan GMBH Company Information
5.10.2 Eusan GMBH Description, Business Overview
5.10.3 Eusan GMBH Dry Eye Drugs Products Offered
5.10.4 Eusan GMBH Dry Eye Drugs Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Eusan GMBH Dry Eye Drugs Sales by Product in 2024
5.10.6 Eusan GMBH Dry Eye Drugs Sales by Application in 2024
5.10.7 Eusan GMBH Dry Eye Drugs Sales by Geographic Area in 2024
5.10.8 Eusan GMBH Recent Developments
6 North America
6.1 North America Dry Eye Drugs Market Size YoY Growth 2020-2031
6.2 North America Dry Eye Drugs Market Facts & Figures by Country
6.2.1 North America Dry Eye Drugs Sales by Country (2020-2031)
6.2.2 North America Dry Eye Drugs Revenue by Country (2020-2031)
6.3 North America Dry Eye Drugs Sales by Type (2020-2025)
6.4 North America Dry Eye Drugs Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Dry Eye Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Dry Eye Drugs Market Facts & Figures by Region
7.2.1 Asia-Pacific Dry Eye Drugs Sales by Region (2020-2031)
7.2.2 Asia-Pacific Dry Eye Drugs Revenue by Region (2020-2031)
7.3 Asia-Pacific Dry Eye Drugs Sales by Type (2020-2025)
7.4 Asia-Pacific Dry Eye Drugs Sales by Application (2020-2025)
8 Europe
8.1 Europe Dry Eye Drugs Market Size YoY Growth 2020-2031
8.2 Europe Dry Eye Drugs Market Facts & Figures by Country
8.2.1 Europe Dry Eye Drugs Sales by Country (2020-2031)
8.2.2 Europe Dry Eye Drugs Revenue by Country (2020-2031)
8.3 Europe Dry Eye Drugs Sales by Type (2020-2025)
8.4 Europe Dry Eye Drugs Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Dry Eye Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Dry Eye Drugs Market Facts & Figures by Country
9.2.1 Latin America Dry Eye Drugs Sales by Country (2020-2031)
9.2.2 Latin America Dry Eye Drugs Revenue by Country (2020-2031)
9.3 Latin America Dry Eye Drugs Sales by Type (2020-2025)
9.4 Latin America Dry Eye Drugs Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Dry Eye Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Dry Eye Drugs Market Facts & Figures by Country
10.2.1 Middle East and Africa Dry Eye Drugs Sales by Country (2020-2031)
10.2.2 Middle East and Africa Dry Eye Drugs Revenue by Country (2020-2031)
10.3 Middle East and Africa Dry Eye Drugs Sales by Type (2020-2025)
10.4 Middle East and Africa Dry Eye Drugs Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Dry Eye Drugs Supply Chain Analysis
11.2 Dry Eye Drugs Key Raw Materials and Upstream Suppliers
11.3 Dry Eye Drugs Clients Analysis
11.4 Dry Eye Drugs Sales Channel and Sales Model Analysis
11.4.1 Dry Eye Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Dry Eye Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Dry Eye Drugs Distributors
12 Dry Eye Drugs Market Dynamics
12.1 Dry Eye Drugs Industry Trends
12.2 Dry Eye Drugs Market Drivers
12.3 Dry Eye Drugs Market Challenges
12.4 Dry Eye Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Dry Eye Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Dry Eye Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Dry Eye Drugs Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Dry Eye Drugs Sales by Region (2020-2025) & (K Units)
 Table 5. Global Dry Eye Drugs Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Dry Eye Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Dry Eye Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Dry Eye Drugs Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Dry Eye Drugs Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Dry Eye Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Dry Eye Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Dry Eye Drugs Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Dry Eye Drugs Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Dry Eye Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Dry Eye Drugs Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Dry Eye Drugs Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Dry Eye Drugs Sales Share by Manufacturer (2020-2025)
 Table 18. Dry Eye Drugs Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Dry Eye Drugs Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Dry Eye Drugs Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Dry Eye Drugs Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Dry Eye Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Dry Eye Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Drugs as of 2024)
 Table 24. Dry Eye Drugs Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Dry Eye Drugs Market
 Table 26. Manufacturers Dry Eye Drugs Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Allergan Company Information
 Table 29. Allergan Description and Business Overview
 Table 30. Allergan Dry Eye Drugs Product
 Table 31. Allergan Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Allergan Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 33. Allergan Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 34. Allergan Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 35. Allergan Recent Developments
 Table 36. Novartis AG Company Information
 Table 37. Novartis AG Description and Business Overview
 Table 38. Novartis AG Dry Eye Drugs Product
 Table 39. Novartis AG Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Novartis AG Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 41. Novartis AG Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 42. Novartis AG Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 43. Novartis AG Recent Developments
 Table 44. Bausch Health Company Information
 Table 45. Bausch Health Description and Business Overview
 Table 46. Bausch Health Dry Eye Drugs Product
 Table 47. Bausch Health Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Bausch Health Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 49. Bausch Health Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 50. Bausch Health Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 51. Bausch Health Recent Developments
 Table 52. Santen Pharma Company Information
 Table 53. Santen Pharma Description and Business Overview
 Table 54. Santen Pharma Dry Eye Drugs Product
 Table 55. Santen Pharma Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Santen Pharma Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 57. Santen Pharma Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 58. Santen Pharma Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 59. Santen Pharma Recent Developments
 Table 60. Takeda Company Information
 Table 61. Takeda Description and Business Overview
 Table 62. Takeda Dry Eye Drugs Product
 Table 63. Takeda Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Takeda Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 65. Takeda Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 66. Takeda Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 67. Takeda Recent Developments
 Table 68. Johnson & Johnson Company Information
 Table 69. Johnson & Johnson Description and Business Overview
 Table 70. Johnson & Johnson Dry Eye Drugs Product
 Table 71. Johnson & Johnson Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Johnson & Johnson Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 73. Johnson & Johnson Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 74. Johnson & Johnson Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 75. Johnson & Johnson Recent Developments
 Table 76. United Laboratories Company Information
 Table 77. United Laboratories Description and Business Overview
 Table 78. United Laboratories Dry Eye Drugs Product
 Table 79. United Laboratories Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. United Laboratories Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 81. United Laboratories Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 82. United Laboratories Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 83. United Laboratories Recent Developments
 Table 84. Senju Pharmaceutical Company Information
 Table 85. Senju Pharmaceutical Description and Business Overview
 Table 86. Senju Pharmaceutical Dry Eye Drugs Product
 Table 87. Senju Pharmaceutical Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Senju Pharmaceutical Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 89. Senju Pharmaceutical Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 90. Senju Pharmaceutical Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 91. Senju Pharmaceutical Recent Developments
 Table 92. Jianfeng Group Company Information
 Table 93. Jianfeng Group Description and Business Overview
 Table 94. Jianfeng Group Dry Eye Drugs Product
 Table 95. Jianfeng Group Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Jianfeng Group Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 97. Jianfeng Group Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 98. Jianfeng Group Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 99. Jianfeng Group Recent Developments
 Table 100. Eusan GMBH Company Information
 Table 101. Eusan GMBH Description and Business Overview
 Table 102. Eusan GMBH Dry Eye Drugs Product
 Table 103. Eusan GMBH Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Eusan GMBH Sales Proportion of Dry Eye Drugs by Product in 2024
 Table 105. Eusan GMBH Sales Proportion of Dry Eye Drugs by Application in 2024
 Table 106. Eusan GMBH Sales Proportion of Dry Eye Drugs by Geographic Area in 2024
 Table 107. Eusan GMBH Recent Developments
 Table 108. North America Dry Eye Drugs Sales by Country (2020-2025) & (K Units)
 Table 109. North America Dry Eye Drugs Sales by Country (2026-2031) & (K Units)
 Table 110. North America Dry Eye Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 111. North America Dry Eye Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 112. North America Dry Eye Drugs Sales by Type (2020-2025) & (K Units)
 Table 113. North America Dry Eye Drugs Sales by Application (2020-2025) & (K Units)
 Table 114. Asia-Pacific Dry Eye Drugs Sales by Region (2020-2025) & (K Units)
 Table 115. Asia-Pacific Dry Eye Drugs Sales by Region (2026-2031) & (K Units)
 Table 116. Asia-Pacific Dry Eye Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 117. Asia-Pacific Dry Eye Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 118. Asia-Pacific Dry Eye Drugs Sales by Type (2020-2025) & (K Units)
 Table 119. Asia-Pacific Dry Eye Drugs Sales by Application (2020-2025) & (K Units)
 Table 120. Europe Dry Eye Drugs Sales by Country (2020-2025) & (K Units)
 Table 121. Europe Dry Eye Drugs Sales by Country (2026-2031) & (K Units)
 Table 122. Europe Dry Eye Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 123. Europe Dry Eye Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 124. Europe Dry Eye Drugs Sales by Type (2020-2025) & (K Units)
 Table 125. Europe Dry Eye Drugs Sales by Application (2020-2025) & (K Units)
 Table 126. Latin America Dry Eye Drugs Sales by Country (2020-2025) & (K Units)
 Table 127. Latin America Dry Eye Drugs Sales by Country (2026-2031) & (K Units)
 Table 128. Latin America Dry Eye Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 129. Latin America Dry Eye Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 130. Latin America Dry Eye Drugs Sales by Type (2020-2025) & (K Units)
 Table 131. Latin America Dry Eye Drugs Sales by Application (2020-2025) & (K Units)
 Table 132. Middle East and Africa Dry Eye Drugs Sales by Country (2020-2025) & (K Units)
 Table 133. Middle East and Africa Dry Eye Drugs Sales by Country (2026-2031) & (K Units)
 Table 134. Middle East and Africa Dry Eye Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 135. Middle East and Africa Dry Eye Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 136. Middle East and Africa Dry Eye Drugs Sales by Type (2020-2025) & (K Units)
 Table 137. Middle East and Africa Dry Eye Drugs Sales by Application (2020-2025) & (K Units)
 Table 138. Dry Eye Drugs Key Raw Materials, Industry Status and Trend
 Table 139. Dry Eye Drugs Key Raw Materials and Upstream Suppliers
 Table 140. Dry Eye Drugs Clients Status and Trend
 Table 141. Dry Eye Drugs Typical Clients
 Table 142. Dry Eye Drugs Distributors
 Table 143. Dry Eye Drugs Market Trends
 Table 144. Dry Eye Drugs Market Drivers
 Table 145. Dry Eye Drugs Market Challenges
 Table 146. Dry Eye Drugs Market Restraints
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Dry Eye Drugs Product Picture
 Figure 2. Global Dry Eye Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Dry Eye Drugs Sales Market Share by Type in 2024 & 2031
 Figure 4. Artificial Tears Product Picture
 Figure 5. Anti-inflammatory Drugs Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Dry Eye Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Dry Eye Drugs Sales Market Share by Application in 2024 & 2031
 Figure 9. Hospital
 Figure 10. Drug Stores
 Figure 11. Online Pharmacies
 Figure 12. Dry Eye Drugs Report Years Considered
 Figure 13. Global Dry Eye Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Dry Eye Drugs Market Size 2020-2031 (US$ Million)
 Figure 15. Global Dry Eye Drugs Sales 2020-2031 (K Units)
 Figure 16. Global Dry Eye Drugs Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Dry Eye Drugs Revenue Market Share by Region (2020-2031)
 Figure 18. Global Dry Eye Drugs Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Dry Eye Drugs Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Dry Eye Drugs Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 21. Global Dry Eye Drugs Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Dry Eye Drugs Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Dry Eye Drugs Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 24. Artificial Tears of Dry Eye Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Anti-inflammatory Drugs of Dry Eye Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Other of Dry Eye Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Global Dry Eye Drugs Sales Share by Manufacturer in 2024
 Figure 28. Dry Eye Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Artificial Tears Market Sales Proportion by Manufacturer in 2024
 Figure 30. Anti-inflammatory Drugs Market Sales Proportion by Manufacturer in 2024
 Figure 31. Other Market Sales Proportion by Manufacturer in 2024
 Figure 32. North America Dry Eye Drugs Revenue 2020-2031 (US$ Million)
 Figure 33. North America Dry Eye Drugs Sales Market Share by Type (2020-2025)
 Figure 34. North America Dry Eye Drugs Sales Market Share by Application (2020-2025)
 Figure 35. Asia-Pacific Dry Eye Drugs Revenue 2020-2031 (US$ Million)
 Figure 36. Asia-Pacific Dry Eye Drugs Sales Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Dry Eye Drugs Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Dry Eye Drugs Sales Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Dry Eye Drugs Sales Market Share by Application (2020-2025)
 Figure 40. Europe Dry Eye Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Dry Eye Drugs Sales Market Share by Country (2020-2031)
 Figure 42. Europe Dry Eye Drugs Revenue Market Share by Country (2020-2031)
 Figure 43. Europe Dry Eye Drugs Sales Market Share by Type (2020-2025)
 Figure 44. Europe Dry Eye Drugs Sales Market Share by Application (2020-2025)
 Figure 45. Latin America Dry Eye Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Latin America Dry Eye Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Dry Eye Drugs Revenue Market Share by Country (2020-2025)
 Figure 48. Latin America Dry Eye Drugs Sales Market Share by Type (2020-2025)
 Figure 49. Latin America Dry Eye Drugs Sales Market Share by Application (2020-2025)
 Figure 50. Middle East and Africa Dry Eye Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Middle East and Africa Dry Eye Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Dry Eye Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Dry Eye Drugs Sales Market Share by Type (2020-2025)
 Figure 54. Middle East and Africa Dry Eye Drugs Sales Market Share by Application (2020-2025)
 Figure 55. Dry Eye Drugs Supply Chain (Upstream and Downstream Market)
 Figure 56. Global Production Market Share of Dry Eye Drugs Raw Materials by Region in 2024
 Figure 57. Dry Eye Drugs Distribution Channels
 Figure 58. Global Dry Eye Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 59. Global Dry Eye Drugs Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools